PROCEPT BioRobotics

IPO

Redefining choices in men's health

Public · San Jose, United States · Founded 2009 · $203.0M raised

Employees
501–1000
Founded
2009
Business Model
B2B
Total Funding
$203.0M
Last Round
$85.0M Series G+Jan 2021
Rounds
2
Type
Public

About

PROCEPT BioRobotics is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company pioneered Aquablation therapy — the only ultrasound-guided, robotic-assisted, waterjet treatment for benign prostatic hyperplasia (BPH) — which delivers significant and long-lasting symptom relief while preserving sexual function and continence across prostates of all shapes and sizes. PROCEPT's latest platform, the HYDROS Robotic System, is an AI-powered next-generation robotic system for Aquablation therapy.

Summary

PROCEPT BioRobotics is a Healthcare company based in San Jose, United States, founded in 2009. It has raised $203.0M in total across 2 rounds, most recently a $85.0M Series G+ round in Jan 2021. Investors include Fidelity Management, Viking Global and Perceptive Advisors.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series G+Series G+Jan 2021
$85.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies